Although several epidemiological studies have investigated lung cancer secondary to breast cancer (11–15), assessed high-risk factors (16–19) for double primary malignancies, and examined the directional associations of estrogen receptor (ER) status (16) in second lung cancers, the clinical characteristics of primary lung cancer following breast cancer have not been comprehensively described. The gene discussed is ESR1; the disease is breast carcinoma.